+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Rodent tissue distribution of 2-cyanoethylene oxide, the epoxide metabolite of acrylonitrile



Rodent tissue distribution of 2-cyanoethylene oxide, the epoxide metabolite of acrylonitrile



Toxicology Letters 69(1): 25-30



The direct acting mutagen 2-cyanoethylene oxide (CEO), formed in the liver by oxidation of acrylonitrile (ACN), is thought to mediate the extrahepatic carcinogenic effects of ACN in rats. This study determined the tissue distribution of CEO (3 mg/kg p.o.) in F-344 rats and B6C3F1 mice. Radioactivity from (2,3-14C)CEO was widely distributed in the major organs of rodents by 2 h and decreased by 71% to 90% within 24 h, demonstrating that there was no preferential tissue uptake or retention of CEO. CEO was detected in rodent blood and brain 5-10 min after an oral dose of ACN (10 mg/kg), demonstrating that this mutagenic epoxide metabolite circulates to extrahepatic target organs following ACN administration.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 009363700

Download citation: RISBibTeXText

PMID: 8356564

DOI: 10.1016/0378-4274(93)90141-j


Related references

Species differences in the hydrolysis of 2 cyanoethylene oxide the epoxide metabolite of acrylonitrile. Proceedings of the American Association for Cancer Research Annual Meeting 32: 118, 1991

Species differences in the hydrolysis of 2-cyanoethylene oxide, the epoxide metabolite of acrylonitrile. Carcinogenesis 14(4): 685-689, 1993

Determination of tissue partition coefficients for volatile tissue-reactive chemicals: acrylonitrile and its metabolite 2-cyanoethylene oxide. Toxicology and Applied Pharmacology 128(1): 92-96, 1994

Accurate quantification of the mercapturic acids of acrylonitrile and its genotoxic metabolite cyanoethylene-epoxide in human urine by isotope-dilution LC-ESI/MS/MS. Talanta 98: 211-219, 2012

Mutagenicity of acrylonitrile and its metabolite 2-cyanoethylene oxide in human lymphoblasts in vitro. Mutation Research 206(2): 297-305, 1988

Conjugation of acrylonitrile and 2-cyanoethylene oxide with hepatic glutathione. Toxicology and Applied Pharmacology 135(1): 9, 1995

In vivo interaction of acrylonitrile and 2-cyanoethylene oxide with DNA in rats. Cancer Research 46(8): 3932-3938, 1986

A physiologically based dosimetry description of acrylonitrile and cyanoethylene oxide in the rat. Toxicology and Applied Pharmacology 134(2): 185-194, 1995

Nucleic Bases Alkylation with Acrylonitrile and Cyanoethylene Oxide: A Computational Study. Chemical Research in Toxicology 31(2): 97, 2018

Synthesis of pentafluorophenylthiohydantoin derivatives of adducts formed with dl-valine by acrylonitrile and cyanoethylene oxide. Tetrahedron Letters 35(22): 3767-3770, 1994

Induction of rat liver microsomal epoxide hydrolase by thiazole and pyrazine: hydrolysis of 2-cyanoethylene oxide. Carcinogenesis 14(8): 1665-1670, 1993

Metabolism of acrylonitrile to 2-cyanoethylene oxide in F-344 rat liver microsomes, lung microsomes, and lung cells. Drug Metabolism and Disposition: the Biological Fate of Chemicals 17(5): 481-486, 1989

Mutagenicity of acrylonitrile (cyanoethylene) in Escherichia coli. Mutation Research 45(2): 283-288, 1977

Acute Toxicity of Acrylonitrile: Effect of Diet on Tissue Nonprotein Sulfhydryl Content and Distribution of 1-:C-Acrylonitrile or Its Metabolites. International Journal of Toxicology 3(1): 93-102, 1984

DNA adducts of propylene oxide and acrylonitrile epoxide: hydrolytic deamination of 3-alkyl-dCyd to 3-alkyl-dUrd. Environmental Health Perspectives 81: 19-22, 1989